These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28115504)

  • 1. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
    Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP
    J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.
    Stevens VW; Nelson RE; Schwab-Daugherty EM; Khader K; Jones MM; Brown KA; Greene T; Croft LD; Neuhauser M; Glassman P; Goetz MB; Samore MH; Rubin MA
    JAMA Intern Med; 2017 Apr; 177(4):546-553. PubMed ID: 28166328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
    Mulherin DW; Hutchison AM; Thomas GJ; Hansen RA; Childress DT
    Infection; 2014 Dec; 42(6):999-1005. PubMed ID: 25129565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.
    Horton HA; Dezfoli S; Berel D; Hirsch J; Ippoliti A; McGovern D; Kaur M; Shih D; Dubinsky M; Targan SR; Fleshner P; Vasiliauskas EA; Grein J; Murthy R; Melmed GY
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5054-9. PubMed ID: 24913174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore.
    Tay HL; Chow A; Ng TM; Lye DC
    Sci Rep; 2019 Sep; 9(1):13440. PubMed ID: 31530847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated disease: adherence with current guidelines at a tertiary medical center.
    Curtin BF; Zarbalian Y; Flasar MH; von Rosenvinge E
    World J Gastroenterol; 2013 Dec; 19(46):8647-51. PubMed ID: 24379582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).
    Manthey CF; Dranova D; Christner M; Drolz A; Kluge S; Lohse AW; Fuhrmann V
    Crit Care; 2019 Dec; 23(1):399. PubMed ID: 31815650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.
    Yoon YK; Kim MJ; Sohn JW; Kim HS; Choi YJ; Kim JS; Kim ST; Park KH; Kim SJ; Kim BS; Shin SW; Kim YH; Park Y
    Support Care Cancer; 2014 Aug; 22(8):2039-48. PubMed ID: 24595407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
    Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
    Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic Therapies for Clostridioides difficile Infection in Children.
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.
    Lee HY; Hsiao HL; Chia CY; Cheng CW; Tsai TC; Deng ST; Chen CL; Chiu CH
    Biomed J; 2019 Apr; 42(2):99-106. PubMed ID: 31130254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of removing metronidazole from treatment armamentarium of mild acute
    Zilberman-Itskovich S; Youngster I; Lazarovitch T; Bondarenco M; Toledano L; Kachlon Y; Mengesha B; Strul N; Zaidenstein R; Marchaim D
    Future Microbiol; 2019 Nov; 14():1489-1495. PubMed ID: 31913060
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications.
    Ohtani M; Yoshizawa S; Miyazaki T; Kumade E; Hirayama S; Sakamoto M; Murakami H; Maeda T; Ishii Y; Matsumoto T; Tateda K
    Jpn J Infect Dis; 2024 Sep; 77(5):281-284. PubMed ID: 38556300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
    Vega AD; Heil EL; Blackman AL; Banoub M; Kristie Johnson J; Leekha S; Claeys KC
    Pharmacotherapy; 2020 May; 40(5):398-407. PubMed ID: 32246501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
    Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.